Diagnosis of gallbladder dyskinesia by quantitative hepatobiliary scintigraphy

Clinical Nuclear Medicine

Volumn 30, Issue 5, 2005, Pages 302-307

  Szepes, Attila ^a   Bertalan, Viktória ^a   Várkonyi, Tamás ^a   Pávics, László ^a   Lonovics, János ^a   Madácsy, László ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

And cholecystokinin; Celiac disease; Cystic duct syndrome; Diabetic neuropathy; Gallbladder dyskinesia; Gallbladder hypomotility; Quantitative hepatobiliary scintigraphy

Indexed keywords

CERULETIDE DIETHYLAMINE; GLYCEROL NITRATE;

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GALLBLADDER DISEASE; GALLBLADDER EMPTYING; GALLBLADDER MOTILITY; HEPATOBILIARY SCINTISCANNING; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

BILIARY DYSKINESIA; BILIARY TRACT; CAERULEIN; FEMALE; GALLBLADDER; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; MALE; MIDDLE AGED; NITROGLYCERIN; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID;

EID: 17644379329     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000159522.19509.30     Document Type: Article

References (30)

1. Corazziari E, Funch-Jensen P, Hogan WJ, et al. Functional disorders of the biliary tract (working team report). Gastroenterology International. 1993;6:129-144.
2. Cozzolino HJ, Goldstein F, Greening RR. The cystic duct syndrome. JAMA. 1963;185:100-104.
3. Toouli J. Biliary tract motor dysfunction. Bailliere's Clinical Gastroenterology. 1991;5:409-431.
4. Sunderland GT, Carter DC. Clinical application of the cholecystokinin provocation test. Br J Surg. 1988;75:444-449.
5. Yap L, Wycherley AG, Morphett AD, et al. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy. Gastroenterology. 1991;101:786-793.
6. Shaffer EA. Cholescintigraphy in acalculous biliary pain: if abnormal, should cholecystectomy follow? Hepatology. 1992;15:737-739.
7. Madácsy L, Velõsy B, Szepes A, et al. Effect of nitric oxide on the gallbladder motility in patients with acalculous biliary pain - a cholescintigraphic study. Dig Dis Sci. 2002;47:1975-1981.
8. Krishnamurthy GT, Bobba VR, Langrell K. The gallbladder emptying response to sequential exogenous and endogenous cholecystokinin. Nucl Med Commun. 1984;5:27-33.
9. Xynos E, Pechlivanides G, Zoras OJ, et al. Reproducibility of gallbladder emptying scintigraphic studies. J Nucl Med. 1994;35:835-839.
10. Sostre S, Canto MI, Kalloo AN. Gallbladder response to a second dose of cholecystokinin during the same imaging study. Eur J Nucl Med. 1992;19:964-965.
11. Garrigues V, Ponce J, Cano C, et al. Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man. Dig Dis Sci. 1992;37:101-104.
12. Madácsy L, Szepes A, Bertalan V, et al. Enhanced filling and caerulein induced emptying of the human gallbladder after glyceryl trinitrate administration - a scintigraphic sign of functional cystic duct syndrome [Case report]. Clin Nucl Med. 2002;27:660-662.
13. Szepes A, Sasi V, Bertalan V, et al. Double blind, placebo controlled ultrasonographic study on the effect of nitric-oxide on the cerulein induced gallbladder contraction in humans. Z Gastroenterol. 39:421, A:167.
14. McKirdy ML, McKirdy HC, Johnson CD. Non-adrenergic non-cholinergic inhibitory innervation shown by electrical field stimulation of isolated strips of human gallbladder muscle. Gut. 1994;35:412-416.
15. Atkins HL, Oster ZH. Asymmetric gallbladder contraction following cholecystokinin hepatobiliary imaging. Clin Nucl Med. 1989;14:83-85.
16. Fink-Bennett D, DeRidder P, Kolozsi WZ, et al. Cholecystokinin cholescintigraphic findings in the cystic duct syndrome. J Nucl Med. 1985;26:1123-1128.
17. Choudhry U, Ruffolo T, Jamidar P, et al. Sphincter of Oddi dysfunction in patients with intact gallbladder: therapeutic response to endoscopic sphincterotomy. Gastrointest Endosc. 1993;39:492-495.
18. Elta GH. Pain and an intact gallbladder: is the sphincter of Oddi to blame? Gastroenterology. 1994;106:1716-1717.
19. Ruffolo TA, Sherman S, Lehman GA, et al. Gallbladder ejection fraction and its relationship to sphincter of Oddi dysfunction. Dig Dis Sci. 1994;39:289-292.
20. Mitsukawa T, Takemura J, Ohgo S, et al. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol. 1990;85:981-985.
21. de Boer SY, Masclee AA, Lam WF, et al. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1994;37:75-81.
22. Palasciano G, Portincasa P, Belfiore A, et al. Gallbladder volume and emptying in diabetics: the role of neuropathy and obesity. J Intern Med. 1992;231:123-127.
23. Thimister PW, Hopman WP, Rosenbusch G, et al. Plasma cholecystokinin and gallbladder responses to increasing doses of bombesin in celiac disease. Dig Dis Sci. 1998;43:668-672.
24. Masclee AA, Jansen JB, Driessen WM, et al. Gallbladder sensitivity to cholecystokinin in coeliac disease. Correlation of gallbladder contraction with plasma cholecystokinin-like immunoreactivity during infusion of cerulein. Scand J Gastroenterol. 1991;26:1279-1284.
25. Masclee AA, Jansen JB, Driessen WM, et al. Gallbladder sensitivity to cholecystokinin in coeliac disease. Correlation of gallbladder contraction with plasma cholecystokinin-like immunoreactivity during infusion of cerulein. Scand J Gastroenterol. 1991;26:1279-1284.
26. Mourelle M, Guarner F, Moncada S, et al. The arginine/nitric oxide pathway modulates sphincter of Oddi motor activity in guinea pigs and rabbits. Gastroenterology. 1993;105:1299-1305.
27. Thune A, Delbro DS, Nilsson B, et al. Role of nitric oxide in motility and secretion of feline hepatobiliary tract. Scand J Gastroenterol. 1995;30:715-720.
28. Salomons H, Keaveny AP, Henihan R, et al. Nitric oxide and gallbladder motility in prairie dogs. Am J Physiol. 1997;272:G770-778.
29. Greaves R, Miller J, O'Donnell L, et al. Effect of the nitric oxide donor, glyceryl trinitrate, on human gall bladder motility. Gut. 1998;42:410-413.
30. Fiorucci S, Distrutti E, Quintieri A, et al. L-arginine/nitric oxide pathway modulates gastric motility and gallbladder emptying induced by erythromycin and liquid meal in humans. Dig Dis Sci. 1995;40:1365-1371.